Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,774 | -11,164 | -6,249 | -6,022 | -7,904 |
| Depreciation Amortization | 660 | 539 | 342 | 303 | 245 |
| Accounts receivable | -751 | 437 | -439 | -40 | -154 |
| Accounts payable and accrued liabilities | -35 | 228 | -112 | -646 | 708 |
| Other Working Capital | -911 | 247 | 1,147 | -891 | 1,114 |
| Other Operating Activity | 2,360 | 4,010 | 4,094 | 2,138 | 504 |
| Operating Cash Flow | $-4,451 | $-5,703 | $-1,217 | $-5,158 | $-5,487 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -437 | -1,461 | -832 | -129 | -139 |
| Purchase Sale Intangibles | -82 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -82 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-519 | $-1,461 | $-832 | $-129 | $-139 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 58 | N/A | N/A |
| Debt Repayment | -24 | -20 | -12 | N/A | N/A |
| Common Stock Issued | 4,489 | 5,447 | 2,777 | 9,418 | 5,244 |
| Other Financing Activity | 0 | -17 | -70 | -73 | -5 |
| Financing Cash Flow | $4,465 | $5,410 | $2,753 | $9,345 | $5,239 |
| Exchange Rate Effect | 60 | 62 | -325 | -13 | -44 |
| Beginning Cash Position | 3,971 | 5,663 | 5,284 | 1,094 | 1,507 |
| End Cash Position | 3,526 | 3,971 | 5,663 | 5,139 | 1,076 |
| Net Cash Flow | $-445 | $-1,692 | $379 | $4,045 | $-431 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,451 | -5,703 | -1,217 | -5,158 | -5,487 |
| Capital Expenditure | -437 | -1,491 | -832 | -129 | -139 |
| Free Cash Flow | -4,888 | -7,194 | -2,049 | -5,287 | -5,626 |